Member Info for Hypermarlin

I did wonder that this was the right interpretation i.e. the course of action for antibody testing is the current stop gap blood tests, and then UK-RTC, nobody else need apply.

Iceman, is there something special you put in your tea?

Per that link, dated 6th August - so that means this is old news and that "This means that Government will not progress new offers for serology testing", from the BIVDA document might suggest UK RTC is not considered a "new offer". We can rest easy?

Premier Trading's post may have considerable significance for us, I just can't see what it is. "Now that our antibody testing programme is up and running and is meeting our current antibody testing needs, the review and triage of new serology technologies undertaken by the New Tests Advisory Group (NTAG) is no longer accepting new serology or antibody tests" does however sound self explanatory. How does this relate to RTC work in Ulster? Anyone know the status of this document and/or the testing processes before the update the Gov't has just published, i.e. what's changed?

Thank you Admin, looks like Mr Ronson has been zapped already.

Report this new character, he's spamming loads of BB with the same ramping nonsense.

@Chughes92 - likewise, I would be grateful for any of the detail of those broker research papers you have access to? Thanks!

@mornington, and so it came to pass...

Here's the link to the Guardian article about the purchase of non-approved tests
https://www.theguardian.com/world/2020/aug/07/revealed-uk-rapid-covid-test-not-yet-approved-by-regulators
Shocking stuff, panic all around.

Well, I'm pleased to report that every 1p rise for me is £220 ish, and oh woe is me it's not in a SIPP or an ISA. I guess I don't need to worry... Still got my training arm bands on and keeping my feet on the bottom anyway.

@Global thanks for your comments. I should have been doing this, maybe, but mostly I've been sat on some initial shares and occasionally adding with new money when they look cheap, buying the dips as they say.

Global, respect to you. May I ask have you had to be out of AVCT for a number of overnights to get to that trading result? I guess if a morning RNS then catches you in cash and not in shares, you can just wait a couple of days for the drift down again. Genuinely interested and trying to hone my approach to these kinds of opportunities.

Sorry AS = CK. Getting all excited.

DHSC quote “We are continually looking for new, innovative approaches as part of our national testing programme,” said a spokesperson. Let's assume (very unsafe to assume anything esp with our government right now) that they are knee deep in discussions with AS as we speak.

Obviously DNANudge will be knocked of its perch (antigen test, at speed) real soon now by AVCT, but: voice interview Bloomberg and CEO here. Gives some validation as to what testing they did, and the extent to which they are now overwhelmed and seeking capital etc. https://www.bloomberg.com/news/audio/2020-08-07/dnanudge-founder-on-device-that-finds-covid-in-90-minutes

Don't forget BBI are likely manufacturing for ODX too, plus whatever else they have on their order book.

@Clive, agree there is lots to like, but for some 50% is no reward for having been in this share since March/April, in and out of the spikes, placements, stress, Sky TV ads, missed opportunities to sell at spikes, been underwater awhile etc etc. It's not as if we are all buying in fresh today. Speaking personally of course. So, 50% would be great, I would be happy frankly with less and with a longer-term story. However, good though that might well be, it's the RTC spike we are all interested in, I think. Then, ha ha, we ALL try to get out at the time time, that should be funny. Not.

xyz - indeed. We can hope that Avacta's IP is behind some pretty impenetrable barriers.

The interview is worth everyone's few minutes, I would say especially including the Daewoong explanation - the potential for what I will call a 'Stem Cell SWAT Team' working magic on damaged tissue whilst also neutralising new attacks from remaining viruses at the same time is boggling stuff. Myles is right of course, this is a long term hold, Affirmers will have many places to go yet to be determined. To say nothing of Avacta's drug conjugate cancer program, which is not mentioned in the interview. DYOR, IMHO etc etc.

@G&A right, so you have to go with 'faith' and press the Place Order button and hope the "market best" they end up with is half way decent and not at the bottom of a drop after the spike. And we all know how trades like those turn out don't we.